Injective (INJ) is currently priced at $5.85, reflecting a 10.67% increase over the past 24 hours. The daily price range has been relatively tight, with a high of $5.93 and a low of $5.28, suggesting bullish momentum in the short term.

Trading volume has reached approximately 88.76 million, indicating a healthy level of market participation, with a volume-to-market cap ratio of 15.14%. The positive change in the shorter moving averages, particularly the 21 SMA at $5.69 (up 2.76%), suggests a potential upward trend, while the 8 SMA at $5.86 shows slight bearish pressure.

The 1-hour RSI sits at 57, indicating that INJ is neither overbought nor oversold, providing room for further upward movement. In contrast, the 7-day RSI at 48 indicates a neutral sentiment, and the recent price changes over the past week (-0.19%), two weeks (-12.95%), and month (-18.93%) indicate a bearish trend over longer periods.

The all-time high for INJ remains significantly distant at $52.62, recorded in March 2024, highlighting substantial potential upside if bullish momentum continues. Current price action relative to key moving averages and RSI metrics suggests that INJ is poised for potential growth in the near term.

Given the recent bullish sentiment and increased trading volume, I recommend a Buy rating for INJ. The positive short-term technical indicators, combined with the relatively healthy market activity, suggest that it could be an opportune time to enter or accumulate more positions before any potential breakout occurs.